Registry for the HeartStart FRx Defibrillator's performance in cardiac arrest cases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects post-event data on the performance of the HeartStart FRx Automated External Defibrillator (AED) used during suspected circulatory arrests. It includes participants who had the device applied, regardless of whether a shock was delivered, ensuring a comprehensive evaluation of the device's safety and clinical performance. The study employs safeguards to minimize selection bias by enrolling all eligible subjects who had the AED pads placed. The registry aims to verify the device's claims as outlined in the Device Manual.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects accepted into the study must: have been suspected of a circulatory arrest for any cause
* Have had HeartStart FRx AED with electrodes: HeartStart SMART PADS II applied to their body and powered up, regardless of whether a defibrillation shock was delivered

Exclusion Criteria:

* AED or pad use other than the HeartStart FRx AED with electrodes : HeartStart SMART PADS II
* AED used for training purposes.

Where it's running

• Philips
  Monroeville, Pennsylvania, United States Recruiting

Study contacts

• Study coordinator: Barb Fink
• Email: barb.fink@philips.com
• Phone: 724-708-7048

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prehospital femoral arterial access to monitor blood pressure during OHCA

  This pilot study tests whether placing a femoral arterial sheath before hospital arrival is feasible and safe in adults with non-traumatic OHCA to enable invasive blood pressure monitoring and better vasopressor control.

  Recruiting Emergency Medical Service, Prague · Prague · NCT07596446

• Predicting sudden cardiac arrest risk in people with coronary artery disease

  This project will try to see if combining genetics, ECGs, blood biomarkers, imaging, and psychosocial information can predict which people with coronary artery disease are most likely to have sudden cardiac arrest.

  Recruiting at 3 sites Tampere Heart Hospital · Hadera and 2 other locations · NCT07444931

• Identifying risk factors for sudden cardiac arrest in coronary artery disease patients

  This study is trying to find out what clinical and genetic factors might increase the risk of sudden cardiac arrest in people with coronary artery disease.

  Recruiting Tampere Heart Hospital · Tampere, Pirkanmaa · NCT06804499

• Genetic assessment of young athletes who experience sudden cardiac arrest during sports

  This study looks at young athletes aged 12 to 35 who have had sudden cardiac arrest during sports to see if genetic factors played a role and to help prevent similar events in others.

  Recruiting at 15 sites Rennes University Hospital · Nîmes, France and 25 other locations · NCT06642168

• Drone-delivered AEDs for cardiac arrests in rural areas

  This project tests whether delivering AEDs by emergency drones to out-of-hospital cardiac arrest sites can reach patients faster than current first responders and EMS in rural communities.

  Recruiting Duke University · Clemmons, North Carolina · NCT06229418

• Evaluation of a wearable defibrillator for sudden cardiac arrest

  This study is testing how well a wearable defibrillator works for people at risk of sudden cardiac arrest by looking at real-life data from patients using the device.

  Recruiting Kestra Medical Technologies, Inc. · Seattle, Washington · NCT05135403

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.